2/13
08:36 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $102.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $102.00 price target on the stock.
2/11
10:13 am
vktx
Why Viking Therapeutics Inc. (VKTX) Went Down on Monday [Yahoo! Finance]
Low
Report
Why Viking Therapeutics Inc. (VKTX) Went Down on Monday [Yahoo! Finance]
2/10
09:10 am
vktx
2 Stocks to Buy With Less Than $40 [Yahoo! Finance]
Medium
Report
2 Stocks to Buy With Less Than $40 [Yahoo! Finance]
2/8
09:44 pm
vktx
2 Stocks That Could Soar Again in 2025 [Yahoo! Finance]
Medium
Report
2 Stocks That Could Soar Again in 2025 [Yahoo! Finance]
2/8
11:13 am
vktx
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip? [Yahoo! Finance]
Medium
Report
Down 65%, Is Viking Therapeutics Stock a Buy on the Dip? [Yahoo! Finance]
2/7
06:25 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its price target lowered by analysts at Maxim Group from $120.00 to $70.00. They now have a "buy" rating on the stock.
Medium
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its price target lowered by analysts at Maxim Group from $120.00 to $70.00. They now have a "buy" rating on the stock.
2/7
12:49 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $96.00 price target on the stock, down previously from $109.00.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $96.00 price target on the stock, down previously from $109.00.
2/7
08:41 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $38.00 price target on the stock.
Medium
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $38.00 price target on the stock.
2/6
03:23 pm
vktx
Viking Therapeutics Reports Q4 2024 Financial Results, Advances VK2735 Trials [Yahoo! Finance]
Low
Report
Viking Therapeutics Reports Q4 2024 Financial Results, Advances VK2735 Trials [Yahoo! Finance]
2/6
03:23 pm
vktx
More on VKTX's Q4 Earnings [Yahoo! Finance]
Neutral
Report
More on VKTX's Q4 Earnings [Yahoo! Finance]
2/6
01:32 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its price target raised by analysts at Raymond James from $122.00 to $125.00. They now have a "strong-buy" rating on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its price target raised by analysts at Raymond James from $122.00 to $125.00. They now have a "strong-buy" rating on the stock.
2/6
08:29 am
vktx
Has the Bubble Burst for Viking Therapeutics Stock? [Yahoo! Finance]
Low
Report
Has the Bubble Burst for Viking Therapeutics Stock? [Yahoo! Finance]
2/6
08:13 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $102.00 price target on the stock.
2/6
08:13 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its price target lowered by analysts at Piper Sandler from $74.00 to $71.00. They now have an "overweight" rating on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its price target lowered by analysts at Piper Sandler from $74.00 to $71.00. They now have an "overweight" rating on the stock.
2/6
06:21 am
vktx
Viking Therapeutics Inc (VKTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising ... [Yahoo! Finance]
Low
Report
Viking Therapeutics Inc (VKTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising ... [Yahoo! Finance]
2/5
06:17 pm
vktx
Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It? [Yahoo! Finance]
Medium
Report
Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It? [Yahoo! Finance]
2/5
05:42 pm
vktx
Viking Therapeutics, Inc. (VKTX): One of January's Biggest Losers [Yahoo! Finance]
Low
Report
Viking Therapeutics, Inc. (VKTX): One of January's Biggest Losers [Yahoo! Finance]
2/5
04:51 pm
vktx
Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
2/5
04:05 pm
vktx
Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
Medium
Report
Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
2/4
05:43 pm
vktx
Viking Therapeutics Q4 2024 Earnings Preview [Seeking Alpha]
Low
Report
Viking Therapeutics Q4 2024 Earnings Preview [Seeking Alpha]
2/2
09:02 am
vktx
Want To Make Money In Biotech Stocks? Check Out OSE Immunotherapeutics [Forbes]
Medium
Report
Want To Make Money In Biotech Stocks? Check Out OSE Immunotherapeutics [Forbes]
1/31
04:00 am
vktx
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know [Yahoo! Finance]
Medium
Report
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know [Yahoo! Finance]
1/29
04:05 pm
vktx
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2024 on February 5, 2025
Low
Report
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2024 on February 5, 2025
1/28
08:11 pm
vktx
Lightning Round: I like WM very much, says Jim Cramer [CNBC]
Low
Report
Lightning Round: I like WM very much, says Jim Cramer [CNBC]
1/28
07:02 pm
vktx
Cramer's Lightning Round: Waste Management is a buy [CNBC]
Low
Report
Cramer's Lightning Round: Waste Management is a buy [CNBC]